Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease (Q28272414)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease
scientific article

    Statements

    Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit